Clinical trial
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno &…
NCT00169442 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00169442 |
|---|---|
| Title | Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants |
| Official title | Immune Memory of GSK's DTPw-HBV/Hib Vaccine by Giving Plain PRP Polysaccharide at 10 Mths. Immuno & Reacto of a Booster Dose of DTPw-HBV/Hib or DTPw-HBV or DTPw-HBV+Hib at 15-18 Mths in Infants Previously Primed With DTPw-HBV/Hib |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Whole Cell Pertussis, Diphtheria, Hepatitis B, Tetanus, Haemophilus Influenzae Type b |
| Intervention type | Biological |
| Interventions | Tritanrix™-HepB/Hiberix™ Kft., Tritanrix™-HepB/Hiberix™, Hiberix™, Polyribosil-Ribitol-Phosphate (PRP) vaccine, Tritanrix™-HepB Kft |
| Enrollment | 745 |
| Start date | Feb 10, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 10, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 6, 2018 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: